Peringkat dalam Saham
#39206
hVIVO plc (HVO) operates as a premier full-service Contract Research... hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of clinical development services to a wide-ranging and growing client base, which includes seven of the world's ten largest biopharmaceutical companies. A key specialisation for hVIVO is orchestrating human challenge trials across numerous infectious and respiratory diseases, utilising its advanced, London-based quarantine facility, the largest of its kind globally. Additionally, the company offers extensive virology and immunology laboratory services through its hLAB division. Through its German subsidiary, CRS, hVIVO manages a 120-bed capacity across sites in Mannheim and Kiel, delivering early-phase clinical trial expertise, including first-in-human and proof-of-concept studies. Its other subsidiary, Venn Life Sciences, contributes to the biopharma sector by providing specialist early drug development consulting and biometry services. The Group collectively offers integrated drug development solutions, covering stages from preclinical research up to Phase II trials, supported by patient recruitment via FluCamp. Moreover, its five clinical sites facilitate outpatient Phase II and III trials, ensuring a streamlined and effective transition from drug discovery to late-stage development.
Kapitalisasi Pasar
$590.13K
Perubahan (1 hari)
-5.97%
Perubahan (1 tahun)
-38.18%
Perdagangan HVIVO plc (HVO)
Riwayat pemecahan saham untuk HVIVO plc (HVO)
Saham HVIVO plc (simbol: HVO) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 14, 2026.
Satu lembar saham HVO yang dibeli sebelum Aug 14, 2026 sekarang setara dengan 0 lembar saham HVO.
Daftar pemecahan saham
| Tahun |
Pemecahan |
Kelipatan |
Kelipatan Kumulatif |
|
Tidak cukup data untuk tanggal yang disediakan. |
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan |
Jumlah pemecahan saham |
Kelipatan Kumulatif |
Negara |
|
|
1 |
x2 |
US
|
|
|
0 |
- |
NL
|
|
|
0 |
- |
CH
|
|
|
0 |
- |
KR
|
|
|
0 |
- |
BE
|